Adaptive Biotechnologies ADPT Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
Based on trailing twelve months.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's interest coverage?
- Adaptive Biotechnologies (ADPT) reported interest coverage of -4× in Q1 2026.
- How has Adaptive Biotechnologies's interest coverage changed year-over-year?
- Adaptive Biotechnologies's interest coverage increased by 68.2% year-over-year, from -12.5× to -4×.
- What is the long-term trend for Adaptive Biotechnologies's interest coverage?
- Over 2 years (2023 to 2025), Adaptive Biotechnologies's interest coverage has grown at a -45.7% compound annual growth rate (CAGR), from -16.5× to -4.9×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.